Document Detail


Failure to reduce cholesterol as explanation for the limited efficacy of antihypertensive treatment in the reduction of CHD. Examination of the evidence from six hypertension intervention trials.
MedLine Citation:
PMID:  3309458     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Over the past 6 years, major hypertension intervention studies in Europe, Australia, and the USA have shown disappointing results in the prevention of coronary heart disease (CHD) in spite of adequate treatment and good compliance. Recently, it has become increasingly clear that hypertensives with or without treatment display higher cholesterol levels than normotensive persons. The present review examines cholesterol levels in six intervention studies, none of which offered dietary or drug therapy for hypercholesterolemic patients. The Oslo study and the British MRC Trial reported very high average cholesterol levels and both showed no protection from CHD through intensive therapy in comparison to control patients. The Australian and the American MRFIT studies produced evidence for reduced coronary mortality among hypertensives with low in contrast to those with high cholesterol levels. The European Working Party showed indirectly that patients with marked reduction in blood pressure and cholesterol had a significantly lower cardiac mortality compared to placebo-treated patients. The IPPPSH study found that increasing cholesterol levels in hypertensives under beta blocker or diuretic therapy increased the risk of myocardial infarction. Failure to reduce cholesterol in hypertensive patients apparently is a major reason for the limited efficacy of antihypertensive treatment in the reduction of CHD.
Authors:
S Heyden; K A Schneider; G J Fodor
Related Documents :
18939908 - Hdl-replacement therapy: mechanism of action, types of agents and potential clinical in...
9139618 - Heparin-induced extracorporeal low-density lipoprotein precipitation and low-density li...
3440388 - Participant recruitment to the lipid research clinics coronary primary prevention trial.
16872968 - Preoperative statin therapy is associated with reduced cardiac mortality after coronary...
1451258 - Endothelial dysfunction in patients with chest pain and normal coronary arteries.
12766528 - Ethnicity and arrhythmias.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Klinische Wochenschrift     Volume:  65     ISSN:  0023-2173     ISO Abbreviation:  Klin. Wochenschr.     Publication Date:  1987 Sep 
Date Detail:
Created Date:  1987-11-17     Completed Date:  1987-11-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  2985205R     Medline TA:  Klin Wochenschr     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  828-32     Citation Subset:  IM    
Affiliation:
Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use*
Cholesterol / blood*
Clinical Trials as Topic
Coronary Disease / blood,  prevention & control*
Humans
Hypertension / blood,  drug therapy*
Risk Factors
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adipose tissue development: the role of precursor cells and adipogenic factors. Part II: The regulat...
Next Document:  Methods for the metabolic quantification of regional myocardial ischemia.